Quest Diagnostics, Inc’s recently made public that its SVP, Clinical Solutions KUPPUSAMY KARTHIK unloaded Company’s shares for reported $1.38 million on Jul 30 ’25. In the deal valued at $167.40 per share,8,269 shares were sold. As a result of this transaction, KUPPUSAMY KARTHIK now holds 10,660 shares worth roughly $1.82 million.
Then, KUPPUSAMY KARTHIK sold 2,210 shares, generating $375,700 in total proceeds. Upon selling the shares at $170.00, the SVP, Clinical Solutions now owns 8,450 shares.
Before that, KUPPUSAMY KARTHIK bought 2,210 shares. Quest Diagnostics, Inc shares valued at $375,700 were divested by the Officer at a price of $170.00 per share.
Redburn Atlantic initiated its Quest Diagnostics, Inc [DGX] rating to a Buy in a research note published on April 02, 2025; the price target was $195. A number of analysts have revised their coverage, including Citigroup’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Neutral”. Leerink Partners also remained covering DGX and has increased its forecast on January 06, 2025 with a “an Outperform” recommendation from previously “Market perform” rating. Morgan Stanley revised its rating on December 17, 2024. It rated DGX as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of DGX
On Friday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock jump 2.05% to $170.85. Over the last five days, the stock has gained 1.36%. Quest Diagnostics, Inc shares have risen nearly 19.57% since the year began. Nevertheless, the stocks have risen 13.25% over the past one year. While a 52-week high of $182.38 was reached on 06/16/25, a 52-week low of $142.86 was recorded on 01/16/25.
Levels Of Support And Resistance For DGX Stock
The 24-hour chart illustrates a support level at 168.57, which if violated will result in even more drops to 166.29. On the upside, there is a resistance level at 172.52. A further resistance level may holdings at 174.19.
How much short interest is there in Quest Diagnostics, Inc?
A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2025-07-15, growing by 0.94 million shares to a total of 4.58 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 3.64 million shares. There was a rise of 20.45%, which implies that there is a positive sentiment for the stock.
